ChemoMetec company profile

CHEMM · Nasdaq Copenhagen · DKK

Compare ChemoMetec
kr 682.00Change from previous close: −2.92%Absolute change: −kr 20.50

Close · November 20, 2026

Company profile

ChemoMetec has 174 employees and is headquartered in Allerød, Denmark.

Analytical equipment for cell counting and analysis forms the core of the business of ChemoMetec, which sells its instruments in the United States, Canada, Europe and other international markets. Its NucleoCounter range, including the NC-3000 image cytometer, the NC-250 automated cell analyzer and the NC-203 cell counter for complex samples, serves customers working on advanced therapies, oncology and stem cell studies, and the development and production of medicines. The line also includes the SP-100 automated sperm cell counter for animal reproduction and the XcytoMatic 40 cell density and viability analyzer. Beyond instruments, the company supplies cassettes, reagents, slides, software, accessories and labware, along with service, validation plans and training, and it also serves the production and quality control of animal semen, milk and beer.

In the fiscal year ended June 2026, revenue was DKK 511.1 million, up 3.1% on the previous year, and net income reached DKK 201.8 million. The company has 174 employees. Its headquarters are in Allerød, Denmark, and it was incorporated in 1997.

Company facts

Industry
Medical Devices
Country
Denmark
Headquarters
Gydevang 43, 3450, Allerød
Employees
174
Chief executive
Martin Behrens
Founded
1997
Fiscal year
July - June
Listing
CHEMM · Nasdaq Copenhagen
Currency
DKK
ISIN
DK0060055861

ChemoMetec and its competitors

The most similar companies by business and size

CompanyCountryMarket capEmployeesOperating marginP/E (trailing 12 months)
ChemoMetecCHEMMDenmark$1.75B17449.1%59.9
El.En.ELNItaly$1.44B1,45914.7%20.7
ElektaEKTA.BSweden$2.27B3,9969.2%—
Medacta GroupMOVESwitzerland$2.41B2,27315.2%27.7
GN Store NordGNDenmark$2.46B7,85610.9%90.2
AmbuAMBU.BDenmark$3.4B4,66413.2%36.7

Competitors: same or related industry, same region first, then the closest market capitalization. Market cap converted into US dollars at the latest exchange rates; P/E over the last 12 months, not shown when negative.

Compare ChemoMetec with its competitors